Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Dormancy and breast cancer.

¹Department of Surgery, University of Massachusetts Medical School, Worcester 01609.

Journal of Surgical Oncology

|March 1, 1990

Summary

Late-recurring breast cancer, appearing decades after treatment, may stem from dormant cancer cells. These cells can reactivate, potentially explaining inflammatory reactions and treatment controversies.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Let us unite against COVID-19 - a New Zealand perspective.

Irish journal of psychological medicine·2020

Same author

Emergent nanoscale superparamagnetism at oxide interfaces.

Nature communications·2016

Same author

A neonatal preventive intervention study: Issues of recruitment and retention.

The journal of primary prevention·2013

Same author

Imaging murine NALT following intranasal immunization with flagellin-modified circumsporozoite protein malaria vaccines.

Mucosal immunology·2013

Same author

Malignant testicular neoplasms in infancy; report of a case with six-year survival.

The New England journal of medicine·2010

Same author

Foreign body perforation of the sigmoid simulating carcinoma.

American journal of surgery·2010

Area of Science:

Oncology
Cell Biology
Immunology

Background:

Breast cancer recurrence can occur decades after initial treatment, posing diagnostic and therapeutic challenges.
Late recurrences are often associated with inflammatory responses and present unique clinical features.
Understanding the mechanisms of cancer cell dormancy and reactivation is crucial for improving patient outcomes.